Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
about
Scutellaria baicalensis decreases ritonavir-induced nauseaLanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherenceAdherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsWhich method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence.Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia.Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials.The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women.Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort studyStrategies for promoting adherence to antiretroviral therapy: a review of the literatureAssociations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.Practical and conceptual challenges in measuring antiretroviral adherence.Drug use and medication adherence among HIV-1 infected individuals.Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia.The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample.Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South AfricaNovel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effectsAdherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR.Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy.Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countriesGenetic therapy for HIV/AIDS.Pharmacists' strategies for promoting medication adherence among patients with HIV.Technology-based self-care methods of improving antiretroviral adherence: a systematic reviewCorrelation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patientsEmtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy.Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya.Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers.Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.Pharmacologic perspectives for once-daily antiretroviral therapy.Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.The MANGUA Project: A Population-Based HIV Cohort in Guatemala.Cultural influences on antiretroviral therapy adherence among HIV-infected Puerto Ricans.Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.Living conditions, quality of life, adherence and treatment outcome in Greenlandic HIV patientsAn empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence.Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence.Significance of variation within HIV, EBV, and KSHV subtypes.Effects of a Phone Call Intervention to Promote Adherence to Antiretroviral Therapy and Quality of Life of HIV/AIDS Patients in Baoshan, China: A Randomized Controlled Trial.
P2860
Q25257431-B7668510-FF66-4FC8-95BC-7DAB8448313CQ27013882-45AF2852-00AC-4919-A293-043B5073E4F2Q28469073-4B83E178-ECA3-4D7E-97FE-B628EC42ED14Q29353869-E8AA8CDD-B179-40FC-977C-6DCBB6BC4F08Q30537713-BC6D1EAB-33ED-4890-A1F2-77C6E5273D2BQ33356236-D904E67F-4582-40A1-BA4F-52604CE641D7Q33707616-FA0D4718-68AF-46ED-ACED-0CDE10025896Q33719127-4F600F41-38FD-4BD7-B80F-DBEF3BA746B4Q33737751-C049F2DE-A3E7-4FAC-9C70-931704F0F2CDQ33764003-2F1511ED-9B08-4876-B7A2-34F97CADCA80Q33814884-0169C225-B4FF-4A51-BD82-AE6D9642F842Q33835857-619E99CB-1379-42A3-88E6-DDEA0CD078BCQ33841530-87EA92CF-0256-4F3D-A39A-998D1705A403Q33851716-654DA5E1-668E-407C-9B38-6687F0DF1B2DQ34335232-D41EB1EA-320E-4CD4-A3B6-2FC8C8401D48Q34480139-A780656E-4F9F-477C-9894-9205974FACA8Q34624904-C9B5B3BC-CCE9-4878-8859-7899933DCBC7Q34691351-755CE167-20A9-4057-9BE3-83FDBA4780DAQ34786563-19DD78D2-D69D-4AB6-B559-61A9AC11F7FEQ35006953-E48574A7-80D3-40E9-B868-2206982C3D93Q35057962-C3A9D0C4-A630-46B3-8F1B-540600B722D7Q35207524-7647BDB9-EF71-47DA-AD25-7370C6415A72Q35212126-FF7B2F4E-B557-45F4-A7EF-D4A74B8607B0Q35582690-E2F32159-DCD1-4897-872B-9058E9008F1BQ35600417-E68C494C-13D3-46AB-945B-D6F6892F8C6BQ35609730-1AB48DB9-7240-49F5-8338-54509CF4AFC2Q35639255-5B2D8F29-FC27-49F4-B954-090991601E83Q35846675-8E7A9E74-E2B3-4FB3-9DFD-200C2CE0361AQ35867142-F97B5609-1A90-4163-8D06-6DD1A15A7EB5Q35915916-E834E00D-2FA5-4B02-A9BD-62DA40D8906FQ36057261-49B5E871-2039-447D-9917-FA04642E828BQ36074672-687FDCFD-5C13-4AA3-AB82-B5E281B25445Q36120560-9CA558EC-61C2-4303-806E-BCF5A916D797Q36153952-44BB44F4-2B19-4556-9AF0-33DF4C52FF50Q36159758-BBA4ECEC-3B1E-4633-8C9D-046057BD7431Q36203449-AF13A1B7-1F19-430C-A2BC-B94A47F80C15Q36210094-3F367269-A864-4864-938B-744ED52E1818Q36503634-82AE9232-6F92-4743-BBFF-818757EEA7A7Q36575166-63E9E673-E361-42EE-9514-88643A78B2D4Q36582487-212BAC61-D797-4596-BE1E-997C5B07BEFA
P2860
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Limited patient adherence to h ...... an observational cohort study.
@ast
Limited patient adherence to h ...... an observational cohort study.
@en
Limited patient adherence to h ...... an observational cohort study.
@nl
type
label
Limited patient adherence to h ...... an observational cohort study.
@ast
Limited patient adherence to h ...... an observational cohort study.
@en
Limited patient adherence to h ...... an observational cohort study.
@nl
prefLabel
Limited patient adherence to h ...... an observational cohort study.
@ast
Limited patient adherence to h ...... an observational cohort study.
@en
Limited patient adherence to h ...... an observational cohort study.
@nl
P2093
P921
P1476
Limited patient adherence to h ...... an observational cohort study
@en
P2093
ATHENA Project
D M Burger
H G Sprenger
M A Chesney
M A Sprangers
M E van Der Ende
M Jambroes
P304
P356
10.1001/ARCHINTE.161.16.1962
P407
P577
2001-09-01T00:00:00Z